SEC

Hywin Holdings and FactSet Launch Global Health Care Index

Retrieved on: 
Thursday, June 30, 2022 - 3:00am
Ageing, Solution, USD, GLOBE, Index, Johnson & Johnson, COVID-19, Company, Industry, FDS, Forward-looking statement, Thermo Fisher Scientific, Terminology, FactSet, Technology, NYSE, HYW, Learning, SEC, Private Securities Litigation Reform Act, NASDAQ, Twitter, Pharmaceutical industry, Asset management, Risk management, Financial services, Pfizer

SHANGHAI, China and HONG KONG, June 30, 2022 (GLOBE NEWSWIRE) -- Hywin Holdings Ltd. ("Hywin Wealth", "Hywin", or the "Company") (NASDAQ: HYW), a leading independent wealth management service provider in China, and FactSet (NYSE: FDS) (NASDAQ: FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced the launch of FactSet Hywin Global Health Care Index (FHGHC) to enable global investors to better capture the investment opportunities within the healthcare industry.

Key Points: 
  • SHANGHAI, China and HONG KONG, June 30, 2022 (GLOBE NEWSWIRE) -- Hywin Holdings Ltd. ("Hywin Wealth", "Hywin", or the "Company") (NASDAQ: HYW), a leading independent wealth management service provider in China, and FactSet (NYSE: FDS) (NASDAQ: FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced the launch of FactSet Hywin Global Health Care Index (FHGHC) to enable global investors to better capture the investment opportunities within the healthcare industry.
  • With a maximum of 5% single-stock weighting, the FactSet Hywin Global Health Care Index represents a diversified and comprehensive benchmark of the global healthcare industry.
  • Hywin, as the source of idea for the index, provides value to clients through offering a learning platform to observe sub-sectors of global healthcare, its various business models and successful companies.
  • FactSet Hywin Global Health Care Index will be published on a daily basis and available on global financial media, data terminals, and broker platforms starting from July 1, 2022.

Verrica Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Thursday, June 30, 2022 - 2:23am
Dermatology, Attention, Molluscum contagiosum, Skin, GLOBE, RBC Capital Markets, Exercise, Sale, Company, U.S. Securities and Exchange Commission, Prospectus, Telephone, Therapy, Wart, Vesey Street, SEC, Risk, Private Securities Litigation Reform Act, NASDAQ, Security (finance), Equity capital markets

WEST CHESTER, Pa., June 29, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the pricing of its underwritten public offering of 12,000,000 shares of its common stock at a price to the public of $2.10 per share.

Key Points: 
  • WEST CHESTER, Pa., June 29, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the pricing of its underwritten public offering of 12,000,000 shares of its common stock at a price to the public of $2.10 per share.
  • In addition, Verrica has granted to the underwriter a 30-day option to purchase up to 1,800,000 additional shares of common stock at the public offering price, less the underwriting discount.
  • The gross proceeds from the offering to Verrica are expected to be approximately $25.2 million, before deducting underwriting discounts and commissions and offering expenses, but excluding any exercise of the underwriters option.
  • However, while Verrica may elect to update these forward-looking statements at some point in the future, Verrica specifically disclaims any obligation to do so.

Grayscale Investments® Initiates Lawsuit Against the SEC

Retrieved on: 
Thursday, June 30, 2022 - 2:03am
GBTC, Review, United States courts of appeals, Securities Exchange Act of 1934, Solicitor General of the United States, Munger, Tolles & Olson, GLOBE, Administration, Grayscale, Davis Polk & Wardwell, U.S. Securities and Exchange Commission, Future Forward Party, ETF, District, LLC, BTC, Investment Company Act of 1940, SEC, Risk, Lovell Minnick Partners, Family, Comment, Security (finance), Wardwell, Cryptocurrency, Bitcoin

“Grayscale supports and believes in the SEC’s mandate to protect investors, maintain fair, orderly, and efficient markets and facilitate capital formation -- and we are deeply disappointed by and vehemently disagree with the SEC's decision to continue to deny spot Bitcoin ETFs from coming to the U.S. market,” said Michael Sonnenshein, Grayscale’s CEO. “Through the ETF application review process, we believe American investors overwhelmingly voiced a desire to see GBTC convert to a spot Bitcoin ETF, which would unlock billions of dollars of investor capital while bringing the world’s largest Bitcoin fund further into the U.S. regulatory perimeter. We will continue to leverage the full resources of the firm to advocate for our investors and the equitable regulatory treatment of Bitcoin investment vehicles.”

Key Points: 
  • NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- Grayscale Investments , the worlds largest digital currency asset manager, today announced that its Senior Legal Strategist, former U.S.
  • Since 2013, Grayscale has worked to build the worlds largest Bitcoin investment vehicle: GBTC.
  • Grayscale has voluntarily filed registration statements with the SEC that have increased information available to investors, and subjected these products to increased SEC oversight.
  • Founded in 2013, Grayscale has a proven track record and deep expertise as the worlds largest digital currency asset manager.

Bragar Eagel & Squire, P.C. Is Investigating Rollins, Lightwave Logic, Target, and Loyalty Ventures and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am
Documentation, Review, Annual report, TGT, U.S. Securities and Exchange Commission, Target, Rollins, EBITDA, GLOBE, Program, Company, Logic, AIR, Miles (given name), NYSE, LightWave 3D, SEC, NASDAQ, Atlantic Canada, News, Alliance Data, Income, Target Corporation, Audit, Renewable energy, Motor vehicle, P.C, Sobeys

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Then, on October 29, 2021, Rollins reported that it had initiated discussions with the SEC staff regarding a potential investigation resolution.
  • On November 5, 2021, Loyalty Ventures became a publicly traded company after its separation from Alliance Data Systems Corporation.
  • For more information on the Loyalty Ventures investigation go to: https://bespc.com/cases/LYLT
    About Bragar Eagel & Squire, P.C.

ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2022

Retrieved on: 
Thursday, June 30, 2022 - 2:23am
Professional Services, Business, Insurance, Finance, Asset Management, Banking, Consolidated, Form 20-F, Workforce, U.S. Securities and Exchange Commission, Annual report, ORIX, IX, Environment, NYSE, Orix, SEC, Bank

ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2022 to the U.S. Securities and Exchange Commission on June 29, 2022.

Key Points: 
  • ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2022 to the U.S. Securities and Exchange Commission on June 29, 2022.
  • Since entering Hong Kong in 1971, ORIX has spread its businesses globally by establishing locations in 28 countries and regions across the world.
  • Going forward, ORIX intends to utilize its strengths and expertise, which generate new value, to establish an independent ORIX business model that continues to evolve perpetually.
  • In this way, ORIX will engage in business activities that instill vitality in its companies and workforce, and thereby contribute to society.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against IonQ, Energy Transfer, Digital Turbine, and Teladoc and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am
Transfer, IonQ, P.C, GLOBE, Growth, Company, Industry, Tax, Mission statement, Tuscarawas River, Teladoc Health, Depreciation, Transport, EBITDA, D2C, Partnership, Form 10-Q, Walmart, NYSE, Natural gas, Complaint, SEC, Energy Transfer Partners, Federal Energy Regulatory Commission, Defendant, Tuscarawas, NGL, TDOC, Technology, NASDAQ, Amazon (company), News, Mental health, BetterHelp, Review, HDD, Energy, FERC, Enforcement, Master limited partnership, Research report, Lists of schools in England, Quantum, Cryptocurrency, Risk management, Audit, Online gambling, Pharmaceutical industry

For more information on the IonQ class action go to: https://bespc.com/cases/IONQ

Key Points: 
  • For more information on the IonQ class action go to: https://bespc.com/cases/IONQ
    Energy Transfer is a Delaware company headquartered in Dallas, Texas.
  • Energy Transfer is a company engaged in natural gas and propane pipeline transport.
  • For more information on the Teladoc class action go to: https://bespc.com/cases/TDOC
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pegasystems, Humbl, Okta, and Enservco and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am
Research, File, GLOBE, Company, Annual report, Wisconsin circuit courts, Mission statement, Class Action, Economy, Securities Act of 1933, University, CNN, Exchange, Disclosure, LLC, Lawsuit, NYSE, SEC, Solution, Twitter, Income, Government, Securities Exchange Act of 1934, Defendant, NASDAQ, News, Complaint, Appian Corporation, Hacking, U.S. Securities and Exchange Commission, Coronavirus, ERCS, OKTA, Lists of schools in England, Relevant, ETX, Reuters, Form 10-K, Circuit court, Risk management, Online gambling, Insurance, Public relations, Renewable energy, Audit, Cryptocurrency, Bank, P.C, Humble Bundle, Okta, Pegasystems, Conduct

stealing, seeking confidential information from a new employee who recently worked for a competitor, or misrepresenting your identity in hopes of obtaining confidential information.

Key Points: 
  • stealing, seeking confidential information from a new employee who recently worked for a competitor, or misrepresenting your identity in hopes of obtaining confidential information.
  • The Appian complaint alleged efforts by PEGA to obtain Appian trade secrets through the contractors employee, who had access to Appians software and materials.
  • For more information on the Enservco class action go to: https://bespc.com/cases/ENSV
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CareDx, Spero, LMP, and Dentsply Sirona and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am
XRAY, Urinary tract infection, Patient, Treatment, GLOBE, Marketing, COVID-19, Growth, Degenerative disease, Company, Complicated, Annual report, CDNA, Food, Mission statement, HBR, Class Action, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NDA, FDA, Population, Tebipenem, Plaque, Dentsply Sirona, SEC, Income, Documentation, Defendant, Workforce, Kidney, New Drug Application, NASDAQ, Board, Medicare, News, ASP, Complaint, Review, California superior courts, Justice, Audit committee, Infection, Sale, Lists of schools in England, Relevant, Risk, LMP, Superior, Spero, Anesthetic, Government, Physician, Pharmaceutical industry, Animal, Renewable energy, Audit, Medical device, Property management, P.C, Pyelonephritis

Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.

Key Points: 
  • Throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the Class Period.
  • For more information on the Dentsply Sirona class action go to: https://bespc.com/cases/XRAY
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Cognyte, Singularity Future, Medallion, and RBB and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, June 30, 2022 - 2:00am
Miner, Charles Ponzi, Royal Business Bank, CEO, Technology, GLOBE, Company, Hindenburg Research, Mining, KOI, RBB, Alpha, EVP, Medal, SEC, Hindenburg, NASDAQ, HuffPost, Run, News, Online gambling, Audit, Cryptocurrency, P.C

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Cognyte's stock fell $3.63, or 31.1%, to close at $8.03 per share on April 5, 2022, thereby injuring investors.
  • For more information on the RBB Bancorp investigation go to: https://bespc.com/cases/RBB
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

JetBlue Comments on Spirit’s Adjournment of Special Meeting

Retrieved on: 
Thursday, June 30, 2022 - 1:29am
Air, Transport, Transportation, Vacation, Destinations, Travel, Annual report, Board of directors, Shearman, Securities Exchange Act of 1934, Securities Act of 1933, Money transmitter, Travel, Fortification, LLP, U.S. Securities and Exchange Commission, Behavior, Letter, Special, SPIRIT, Disease, JBLU, Public health, Forward-looking statement, BLUE, ALL, NYSE, Private Securities Litigation Reform Act, Frontier, Goldman Sachs, SEC, City, NASDAQ, Shearman & Sterling, Ouija, Coronavirus, Management, Airline, Security (finance), Auction, JetBlue, Spirit

Its clear that Spirit shareholders have now handed the Spirit Board an undeniable mandate to reach an agreement with JetBlue.

Key Points: 
  • Its clear that Spirit shareholders have now handed the Spirit Board an undeniable mandate to reach an agreement with JetBlue.
  • Goldman Sachs & Co. LLC is serving as JetBlues financial advisor and Shearman & Sterling LLP is serving as JetBlues legal advisor.
  • JetBlue is New York's Hometown Airline, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando, and San Juan.
  • JetBlue carries customers to more than 100 cities throughout the United States, Latin America, Caribbean, Canada, and United Kingdom.